“…In the case of the Leb antigen, the situation is rather similar to that of the A and B antigens. Its level of expression is increased in carcinomas from the distal colon, the rectum, the thyroid and the liver (28,45,47,54,(72)(73)(74)(75), but also from the urinary bladder, while it decreases in stomach carcinomas (59,62,64). Finally, the Ley antigen has its expression strongly augmented in nearly all types of carcinomas (17, 28, 35, 40, 41, 4 3 4 5 , 48, 72, 73, [76][77][78][79][80][81] with the exception of the pancreatic and possibly endometrial carcinomas for which a decrease has been reported (58,70,7 1,82).…”